PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results
Lucid secured capital to extend runway well past key upcoming reimbursement milestones; ended 1Q25 with over $40 million in proforma...
DNA
Lipella Pharmaceuticals to Present Phase 2a Data for LP-310 in Oral Lichen Planus at 2025 AAOM/EAOM International Meeting
Statistically significant safety and efficacy data from 0.25 mg and 0.50 mg cohorts to be presented Presentation scheduled for Thursday,...
Excision BioTherapeutics Announces Publication Highlighting EBT-107 for the Treatment of Chronic Hepatitis B in bioRxiv
Treatment with EBT-107 led to a rapid reduction in clinical biomarkers and suppression of random HBV DNA integration with minimal...
Plasmidsaurus Launches Fast, Low-Input AAV Genome Sequencing Service to Accelerate Gene Therapy R&D
SOUTH SAN FRANCISCO, Calif. , May 14, 2025 /PRNewswire/ -- Plasmidsaurus, the company that sequences while you sleep, today announced...
UPDATE — Abeona Therapeutics® and Lurie Children’s Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder
- ZEVASKYN, the first and only cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), now commercially available...
Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing
IRVINE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, developer of GlutenID, the first and only U.S. Food...
Hydreight Technologies to Present at Maxim Group’s 2025 Virtual Tech Conference & the CEM Bermuda Capital Event
VANCOUVER, British Columbia and LAS VEGAS, May 14, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV:...
Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications
Building on reputation for unparalleled performance, latest software delivers even greater accuracy, with 30% improvement in structural variant calling New...
Capricor Therapeutics Appoints Michael Binks, M.D. as Chief Medical Officer
— Dr. Binks joins Capricor in anticipation of potential approval of deramiocel in Q3 2025, bringing extensive experience in neuromuscular...
Excision BioTherapeutics Presents Data from HBV and HSV Programs at the ASGCT 2025 Annual Meeting
Poster presentation to demonstrate EBT-107’s potential to reduce clinically-relevant biomarkers and HBV DNA integration toward functional remission of chronic hepatitis...
GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL’s Galleri® Multi-Cancer Early Detection (MCED) Test
MENLO PARK, Calif., May 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect...
MEDVi Under Review: Best GLP-1 Semaglutide & Terzepatide Compound Solution for Personalized Weight Loss
A Comprehensive Review of MEDVi’s Personalized GLP-1 Weight Loss Solutions Featuring Affordable Compounded Semaglutide and Tirzepatide Delivered via TelehealthNew York,...
Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM
Toronto, Ontario--(Newsfile Corp. - May 9, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical...
YouScript Wins “PharmaTech Innovation Award” in 9th Annual MedTech Breakthrough Awards Program
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies SEATTLE, May 8, 2025 /PRNewswire/...
Cyient’s Expertise Acknowledged with Leadership Rankings in Nine Verticals by Zinnov
HYDERABAD, India and DALLAS, May 8, 2025 /PRNewswire/ -- Cyient Limited, a global Intelligent Engineering solutions company, has been recognized as...
LiveWorld Reports First Quarter 2025 Financial Results
LiveWorld looks to increase its AI investmentCAMPBELL, Calif. and NEW YORK , May 08, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc....
GenoFAB Announces Publication of Groundbreaking Self-Documenting Plasmid Technology In Trends In Biotechnology
The publication introduces a genetic identification system that enables plasmids to carry embedded documentation, improving traceability, verification, and secure exchange...
OrthAlign Welcomes Brett Brodnax to Board of Directors, Marking a Strategic Step Forward in ASC Innovation and Growth
IRVINE, Calif., May 7, 2025 /PRNewswire/ -- OrthAlign, Inc., a global provider of simple, efficient, and clinically impactful technologies for...
MyOme and Collective Health® Partner to Expand Access to MyOme’s Whole-Genome Based Products for Employers
The new joint initiative with The Partner Collective® by Collective Health® will allow employers to empower their workforces with MyOme's...
STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update
HORSHAM, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical...